Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q0IM
|
|||
| Drug Name |
SNA-125
|
|||
| Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 1 | [1] | |
| Pruritus [ICD-11: EC90; ICD-10: L29, L29.9; ICD-9: 698] | Phase 1 | [1] | ||
| Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 1 | [1] | ||
| Company |
Sienna Biopharmaceuticals Westlake Village, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.